- Filed
- May 1, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · Apr 28, 2025 | 5.79M sh |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $40.26M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $55.7M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $25.88M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $32.88M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $107.07M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $124.3M |
| Current Assets | Q1 2025 · Mar 31, 2025 | $95.7M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $112.18M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $130.01M |
| Total Assets | Q1 2025 · Dec 31, 2024 | $146.45M |
| Shares Diluted restated | Q1 2025 · Mar 31, 2024 | 6.67M sh |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | −$33.6M |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | $1.04M |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | $51.1M |
| Eps Diluted restated | Q1 2025 · Mar 31, 2024 | −$7.77 |
| Eps Basic restated | Q1 2025 · Mar 31, 2024 | −$7.77 |
| Sga Expense | Q1 2025 · Mar 31, 2024 | $17.44M |
| Rd Expense | Q1 2025 · Mar 31, 2024 | $19.85M |
| Net Income | Q1 2025 · Mar 31, 2024 | −$51.77M |
| Operating Income | Q1 2025 · Mar 31, 2024 | −$37.29M |
| Cost Of Revenue | Q1 2025 · Mar 31, 2024 | $0 |
| Revenue | Q1 2025 · Mar 31, 2024 | $0 |